<DOC>
	<DOC>NCT02863757</DOC>
	<brief_summary>The purpose of this study is to determine the disease progression in CHB/NAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma (HCC).</brief_summary>
	<brief_title>Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Hepatitis B, Chronic</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Liver biopsy proved CHB and/or NAFLD at baseline; Chinese Followup duration&gt;12 months Other liver diseases; Secondary causes of hepatic steatosis; Alcohol abuse; Liver cirrhosis, cirrhosis related complications or HCC at baseline; Malignancy; History of liver transplantation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>